Which retatrutide effects came from human tests?
Human tests found lower weight, nausea, and a quicker resting pulse. Other changes come only from personal reports.
Which retatrutide effects have human test support?
As of 2026, no country had approved retatrutide. Fair human tests found falling weight, a sick stomach, better blood sugar, and a quicker resting pulse.
Reports from people who bought vials sold only for lab research are much less sure. The vial may differ from the study drug, and no study doctor watched the person.
Personal reports can raise questions, but they can’t show that retatrutide caused a change. This page gives you no amount for personal use.
Which retatrutide effects come only from personal reports?
These are personal reports, not results from a controlled study. People bought retatrutide sold for lab research, and the small Phase 1 test didn’t check these claims.
Labels such as “reported often” only mean that a claim appears often in online talk. They don’t tell you the chance that the same thing would happen to you.
Far less hunger while thoughts about food faded (reported often): People say food took up less of their attention. They describe little wish to eat, instead of feeling stuffed.
Fast, marked weight loss (reported often): Some people felt the scale moved at a quicker pace than it had with earlier medicines. A Phase 2 test found about 24% average loss, but that result can’t prove their stories [1].
Some people noticed the scale change within the first several weeks. The reports varied too much to count as human test results.
Feeling warmer (reported fairly often): Some people say they felt warm, flushed, or sweaty without hard work. They blame extra calories burned while resting, an idea that no fair study has tested.
A faster resting pulse (reported fairly often): Some people say a watch showed a quicker heartbeat after a shot. Those watch readings haven’t been checked, though a Phase 2 test did find a higher resting pulse [1].
Nausea early on or after an increase (reported often): Nausea appears in many personal reports. People say it may start soon after a shot and then ease as weeks pass.
Sulfur-smelling burps (reported fairly often): People describe belches with a sulfur smell. They think food remaining in the stomach for more time causes it, but a fair study has never checked that idea.
Tiredness early on (reported fairly often): Some describe weak legs, more need for sleep, or foggy thinking. They often blame eating far less, and the cause remains untested in a fair study.
Constipation (reported fairly often): Some people say bowel movements came less often. Smaller meals and a slower bowel could each play a part.
Itching or redness at the shot site (reported now and then): People say the spot may itch or turn red for a day or two after the shot was given. A reaction there occurred in about 8% during Phase 2 [1].
Poor sleep (reported now and then): Some people say sleep was hard to start or keep. They blame warmth or changed meal times, yet a fair study hasn’t tested those ideas.
A better mood (reported now and then): Some people say fewer thoughts about food made meals feel easier. Work on hunger can’t prove that retatrutide changed anyone’s mood.
Loss of muscle and tissue besides fat (reported now and then): Some people feared weaker or less firm muscles. Body scans in Phase 2 found some muscle loss and loss of other tissue that was not fat, though much more fat was lost [1].
Which retatrutide safety risks matter most?
Human studies found the risks below; drug law tells you retatrutide isn’t approved. Each small source number points to the paper behind the fact.
No approval and no sure contents from unofficial sellers [1][6]: The FDA hadn’t approved retatrutide by mid-2026. A vial from an unofficial seller may contain another drug, the wrong strength, or germs that cause a deadly infection.
Lab checks of test drugs from such sellers have found damaged material or the wrong medicine. In 2025, the FDA sent over 50 warning letters to retatrutide sellers.
Stomach and bowel trouble [1][9][10]: Phase 1 and Phase 2 both found nausea, vomiting, diarrhea, and constipation. Nausea affected up to 45% at the largest amount, and side effects led 18% to quit.
Retatrutide can make food remain in the stomach for more time and slow the bowel. Bad diarrhea or vomiting may dry out your body, especially without a doctor watching you.
A resting pulse that rises with the amount [1][8][7]: At the highest Phase 2 amounts, the average pulse rose about 5-7 beats each minute and peaked near 24 weeks. The small Phase 1 test was too short to show what years of a faster pulse might do.
A large heart test hasn’t reported. Until it does, doctors can’t know whether years of a faster pulse could lead to an uneven beat or make the heart work too hard inside a living person.
Blood sugar that falls too low [2][4]: Insulin is a hormone that carries sugar out of your bloodstream and into your cells. Taking insulin with pills that force the pancreas to release still more insulin can push blood sugar below a safe point.
In Phase 2, people already taking insulin had that medicine cut back. The study doctors watched them closely during the change.
Muscle loss and loss of tissue that was not fat [11]: In 2025, body scans of people with type 2 diabetes found loss of muscle plus other tissue that was not fat. Losing that tissue can hit an older or frail person harder.
What long use may do [11][12][7][8]: No one knows whether weight stays off after retatrutide stops. Large tests are still looking for later harm to your heart and kidneys.
The Phase 1 test was too short to answer what happens after years. Phase 2 also couldn’t show whether weight returns after stopping, and a large kidney study is still under way.